nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—Dementia—Methotrexate—muscle cancer	0.0416	0.0416	CcSEcCtD
Tolterodine—Urinary retention—Vincristine—muscle cancer	0.0243	0.0243	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Etoposide—muscle cancer	0.0214	0.0214	CcSEcCtD
Tolterodine—Dysuria—Vincristine—muscle cancer	0.0206	0.0206	CcSEcCtD
Tolterodine—Flushing—Dactinomycin—muscle cancer	0.0183	0.0183	CcSEcCtD
Tolterodine—Hallucination—Vincristine—muscle cancer	0.0176	0.0176	CcSEcCtD
Tolterodine—Influenza like illness—Doxorubicin—muscle cancer	0.0143	0.0143	CcSEcCtD
Tolterodine—Oedema—Dactinomycin—muscle cancer	0.014	0.014	CcSEcCtD
Tolterodine—Infection—Dactinomycin—muscle cancer	0.0139	0.0139	CcSEcCtD
Tolterodine—Vertigo—Vincristine—muscle cancer	0.0138	0.0138	CcSEcCtD
Tolterodine—Dry eye—Doxorubicin—muscle cancer	0.0136	0.0136	CcSEcCtD
Tolterodine—Flushing—Etoposide—muscle cancer	0.0133	0.0133	CcSEcCtD
Tolterodine—Abnormal vision—Doxorubicin—muscle cancer	0.0129	0.0129	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.0128	0.0128	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.0128	0.0128	CcSEcCtD
Tolterodine—Anaphylactic shock—Vincristine—muscle cancer	0.0125	0.0125	CcSEcCtD
Tolterodine—Oedema—Vincristine—muscle cancer	0.0125	0.0125	CcSEcCtD
Tolterodine—Infection—Vincristine—muscle cancer	0.0125	0.0125	CcSEcCtD
Tolterodine—Fatigue—Dactinomycin—muscle cancer	0.0121	0.0121	CcSEcCtD
Tolterodine—Pain—Dactinomycin—muscle cancer	0.012	0.012	CcSEcCtD
Tolterodine—Feeling abnormal—Dactinomycin—muscle cancer	0.0116	0.0116	CcSEcCtD
Tolterodine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0115	0.0115	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0114	0.0114	CcSEcCtD
Tolterodine—Vertigo—Etoposide—muscle cancer	0.0112	0.0112	CcSEcCtD
Tolterodine—Abdominal pain—Dactinomycin—muscle cancer	0.0111	0.0111	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.0111	0.0111	CcSEcCtD
Tolterodine—Fatigue—Vincristine—muscle cancer	0.0108	0.0108	CcSEcCtD
Tolterodine—Constipation—Vincristine—muscle cancer	0.0107	0.0107	CcSEcCtD
Tolterodine—Pain—Vincristine—muscle cancer	0.0107	0.0107	CcSEcCtD
Tolterodine—Chest pain—Etoposide—muscle cancer	0.0106	0.0106	CcSEcCtD
Tolterodine—Hypersensitivity—Dactinomycin—muscle cancer	0.0103	0.0103	CcSEcCtD
Tolterodine—Gastrointestinal pain—Vincristine—muscle cancer	0.0103	0.0103	CcSEcCtD
Tolterodine—Confusional state—Etoposide—muscle cancer	0.0102	0.0102	CcSEcCtD
Tolterodine—Anaphylactic shock—Etoposide—muscle cancer	0.0102	0.0102	CcSEcCtD
Tolterodine—Infection—Etoposide—muscle cancer	0.0101	0.0101	CcSEcCtD
Tolterodine—Asthenia—Dactinomycin—muscle cancer	0.0101	0.0101	CcSEcCtD
Tolterodine—Dysuria—Methotrexate—muscle cancer	0.01	0.01	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00994	0.00994	CcSEcCtD
Tolterodine—Tachycardia—Etoposide—muscle cancer	0.00991	0.00991	CcSEcCtD
Tolterodine—Abdominal pain—Vincristine—muscle cancer	0.00991	0.00991	CcSEcCtD
Tolterodine—Dry skin—Doxorubicin—muscle cancer	0.00982	0.00982	CcSEcCtD
Tolterodine—Diarrhoea—Dactinomycin—muscle cancer	0.0096	0.0096	CcSEcCtD
Tolterodine—Hypersensitivity—Vincristine—muscle cancer	0.00924	0.00924	CcSEcCtD
Tolterodine—Somnolence—Etoposide—muscle cancer	0.00903	0.00903	CcSEcCtD
Tolterodine—Asthenia—Vincristine—muscle cancer	0.009	0.009	CcSEcCtD
Tolterodine—Bronchitis—Doxorubicin—muscle cancer	0.00891	0.00891	CcSEcCtD
Tolterodine—Fatigue—Etoposide—muscle cancer	0.00876	0.00876	CcSEcCtD
Tolterodine—Pain—Etoposide—muscle cancer	0.00869	0.00869	CcSEcCtD
Tolterodine—Constipation—Etoposide—muscle cancer	0.00869	0.00869	CcSEcCtD
Tolterodine—Dysuria—Doxorubicin—muscle cancer	0.00866	0.00866	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00861	0.00861	CcSEcCtD
Tolterodine—Diarrhoea—Vincristine—muscle cancer	0.00858	0.00858	CcSEcCtD
Tolterodine—Weight increased—Doxorubicin—muscle cancer	0.00843	0.00843	CcSEcCtD
Tolterodine—Feeling abnormal—Etoposide—muscle cancer	0.00837	0.00837	CcSEcCtD
Tolterodine—Gastrointestinal pain—Etoposide—muscle cancer	0.00831	0.00831	CcSEcCtD
Tolterodine—Dizziness—Vincristine—muscle cancer	0.00829	0.00829	CcSEcCtD
Tolterodine—Visual impairment—Methotrexate—muscle cancer	0.00825	0.00825	CcSEcCtD
Tolterodine—Abdominal pain—Etoposide—muscle cancer	0.00803	0.00803	CcSEcCtD
Tolterodine—Urinary tract infection—Doxorubicin—muscle cancer	0.00803	0.00803	CcSEcCtD
Tolterodine—Headache—Vincristine—muscle cancer	0.00786	0.00786	CcSEcCtD
Tolterodine—Sinusitis—Doxorubicin—muscle cancer	0.00775	0.00775	CcSEcCtD
Tolterodine—Hypersensitivity—Etoposide—muscle cancer	0.00748	0.00748	CcSEcCtD
Tolterodine—Oedema peripheral—Doxorubicin—muscle cancer	0.0073	0.0073	CcSEcCtD
Tolterodine—Asthenia—Etoposide—muscle cancer	0.00729	0.00729	CcSEcCtD
Tolterodine—Visual impairment—Doxorubicin—muscle cancer	0.00715	0.00715	CcSEcCtD
Tolterodine—Diarrhoea—Etoposide—muscle cancer	0.00695	0.00695	CcSEcCtD
Tolterodine—Flushing—Doxorubicin—muscle cancer	0.00688	0.00688	CcSEcCtD
Tolterodine—Dizziness—Etoposide—muscle cancer	0.00672	0.00672	CcSEcCtD
Tolterodine—Vertigo—Methotrexate—muscle cancer	0.0067	0.0067	CcSEcCtD
Tolterodine—Headache—Etoposide—muscle cancer	0.00636	0.00636	CcSEcCtD
Tolterodine—Flatulence—Doxorubicin—muscle cancer	0.00636	0.00636	CcSEcCtD
Tolterodine—Chest pain—Methotrexate—muscle cancer	0.00635	0.00635	CcSEcCtD
Tolterodine—Arthralgia—Methotrexate—muscle cancer	0.00635	0.00635	CcSEcCtD
Tolterodine—Confusional state—Methotrexate—muscle cancer	0.00613	0.00613	CcSEcCtD
Tolterodine—Anaphylactic shock—Methotrexate—muscle cancer	0.00608	0.00608	CcSEcCtD
Tolterodine—Infection—Methotrexate—muscle cancer	0.00604	0.00604	CcSEcCtD
Tolterodine—Vertigo—Doxorubicin—muscle cancer	0.0058	0.0058	CcSEcCtD
Tolterodine—Palpitations—Doxorubicin—muscle cancer	0.0057	0.0057	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00554	0.00554	CcSEcCtD
Tolterodine—Arthralgia—Doxorubicin—muscle cancer	0.0055	0.0055	CcSEcCtD
Tolterodine—Chest pain—Doxorubicin—muscle cancer	0.0055	0.0055	CcSEcCtD
Tolterodine—Anxiety—Doxorubicin—muscle cancer	0.00548	0.00548	CcSEcCtD
Tolterodine—Somnolence—Methotrexate—muscle cancer	0.00541	0.00541	CcSEcCtD
Tolterodine—Dry mouth—Doxorubicin—muscle cancer	0.00537	0.00537	CcSEcCtD
Tolterodine—Dyspepsia—Methotrexate—muscle cancer	0.00536	0.00536	CcSEcCtD
Tolterodine—Confusional state—Doxorubicin—muscle cancer	0.00531	0.00531	CcSEcCtD
Tolterodine—Oedema—Doxorubicin—muscle cancer	0.00527	0.00527	CcSEcCtD
Tolterodine—Anaphylactic shock—Doxorubicin—muscle cancer	0.00527	0.00527	CcSEcCtD
Tolterodine—Fatigue—Methotrexate—muscle cancer	0.00525	0.00525	CcSEcCtD
Tolterodine—Infection—Doxorubicin—muscle cancer	0.00523	0.00523	CcSEcCtD
Tolterodine—Pain—Methotrexate—muscle cancer	0.0052	0.0052	CcSEcCtD
Tolterodine—Tachycardia—Doxorubicin—muscle cancer	0.00514	0.00514	CcSEcCtD
Tolterodine—Feeling abnormal—Methotrexate—muscle cancer	0.00501	0.00501	CcSEcCtD
Tolterodine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00498	0.00498	CcSEcCtD
Tolterodine—Abdominal pain—Methotrexate—muscle cancer	0.00481	0.00481	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.0048	0.0048	CcSEcCtD
Tolterodine—Somnolence—Doxorubicin—muscle cancer	0.00468	0.00468	CcSEcCtD
Tolterodine—Dyspepsia—Doxorubicin—muscle cancer	0.00464	0.00464	CcSEcCtD
Tolterodine—Fatigue—Doxorubicin—muscle cancer	0.00454	0.00454	CcSEcCtD
Tolterodine—Constipation—Doxorubicin—muscle cancer	0.00451	0.00451	CcSEcCtD
Tolterodine—Pain—Doxorubicin—muscle cancer	0.00451	0.00451	CcSEcCtD
Tolterodine—Hypersensitivity—Methotrexate—muscle cancer	0.00448	0.00448	CcSEcCtD
Tolterodine—Asthenia—Methotrexate—muscle cancer	0.00437	0.00437	CcSEcCtD
Tolterodine—Feeling abnormal—Doxorubicin—muscle cancer	0.00434	0.00434	CcSEcCtD
Tolterodine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00431	0.00431	CcSEcCtD
Tolterodine—Abdominal pain—Doxorubicin—muscle cancer	0.00416	0.00416	CcSEcCtD
Tolterodine—Diarrhoea—Methotrexate—muscle cancer	0.00416	0.00416	CcSEcCtD
Tolterodine—Dizziness—Methotrexate—muscle cancer	0.00402	0.00402	CcSEcCtD
Tolterodine—Hypersensitivity—Doxorubicin—muscle cancer	0.00388	0.00388	CcSEcCtD
Tolterodine—Headache—Methotrexate—muscle cancer	0.00381	0.00381	CcSEcCtD
Tolterodine—Asthenia—Doxorubicin—muscle cancer	0.00378	0.00378	CcSEcCtD
Tolterodine—Diarrhoea—Doxorubicin—muscle cancer	0.0036	0.0036	CcSEcCtD
Tolterodine—Dizziness—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Tolterodine—Headache—Doxorubicin—muscle cancer	0.0033	0.0033	CcSEcCtD
